Literature DB >> 27746256

Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways.

Jessica Brandi1, Ilaria Dando2, Elisa Dalla Pozza2, Giulia Biondani2, Rosalind Jenkins3, Victoria Elliott4, Kevin Park3, Giuseppina Fanelli5, Lello Zolla5, Eithne Costello4, Aldo Scarpa6, Daniela Cecconi7, Marta Palmieri2.   

Abstract

Recently, we have shown that the secretome of pancreatic cancer stem cells (CSCs) is characterized by proteins that participate in cancer differentiation, invasion, and metastasis. However, the differentially expressed intracellular proteins that lead to the specific characteristics of pancreatic CSCs have not yet been identified, and as a consequence the deranged metabolic pathways are yet to be elucidated. To identify the modulated proteins of pancreatic CSCs, iTRAQ-based proteomic analysis was performed to compare the proteome of Panc1 CSCs and Panc1 parental cells, identifying 230 modulated proteins. Pathway analysis revealed activation of glycolysis, the pentose phosphate pathway, the pyruvate-malate cycle, and lipid metabolism as well as downregulation of the Krebs cycle, the splicesome and non-homologous end joining. These findings were supported by metabolomics and immunoblotting analysis. It was also found that inhibition of fatty acid synthase by cerulenin and of mevalonate pathways by atorvastatin have a greater anti-proliferative effect on cancer stem cells than parental cells. Taken together, these results clarify some important aspects of the metabolic network signature of pancreatic cancer stem cells, shedding light on key and novel therapeutic targets and suggesting that fatty acid synthesis and mevalonate pathways play a key role in ensuring their viability. BIOLOGICAL SIGNIFICANCE: To better understand the altered metabolic pathways of pancreatic cancer stem cells (CSCs), a comprehensive proteomic analysis and metabolite profiling investigation of Panc1 and Panc1 CSCs were carried out. The findings obtained indicate that Panc1 CSCs are characterized by upregulation of glycolysis, pentose phosphate pathway, pyruvate-malate cycle, and lipid metabolism and by downregulation of Krebs cycle, spliceosome and non-homologous end joining. Moreover, fatty acid synthesis and mevalonate pathways are shown to play a critical contribution to the survival of pancreatic cancer stem cells. This study is helpful for broadening the knowledge of pancreatic cancer stem cells and could accelerate the development of novel therapeutic strategies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Pancreatic cancer; Pancreatic ductal adenocarcinoma PDAC

Mesh:

Substances:

Year:  2016        PMID: 27746256     DOI: 10.1016/j.jprot.2016.10.002

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  30 in total

Review 1.  The Warburg Effect and Mass Spectrometry-based Proteomic Analysis.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

Review 2.  Metabolism and epigenetics of pancreatic cancer stem cells.

Authors:  M Perusina Lanfranca; J K Thompson; F Bednar; C Halbrook; C Lyssiotis; B Levi; T L Frankel
Journal:  Semin Cancer Biol       Date:  2018-09-28       Impact factor: 15.707

Review 3.  Emerging roles of lipid metabolism in cancer metastasis.

Authors:  Xiangjian Luo; Can Cheng; Zheqiong Tan; Namei Li; Min Tang; Lifang Yang; Ya Cao
Journal:  Mol Cancer       Date:  2017-04-11       Impact factor: 27.401

4.  Proteins and Molecular Pathways Relevant for the Malignant Properties of Tumor-Initiating Pancreatic Cancer Cells.

Authors:  Lisa Samonig; Andrea Loipetzberger; Constantin Blöchl; Marc Rurik; Oliver Kohlbacher; Fritz Aberger; Christian G Huber
Journal:  Cells       Date:  2020-06-03       Impact factor: 6.600

5.  Untargeted LC-MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate.

Authors:  Feng Wang; Zhiyu Zhang; Qin Li; Tao Yu; Chengbin Ma
Journal:  Cancer Cell Int       Date:  2020-06-24       Impact factor: 5.722

6.  Cells with stemness features are generated from in vitro transformed human fibroblasts.

Authors:  Bartolo Bono; Paola Ostano; Martina Peritore; Ilaria Gregnanin; Cristina Belgiovine; Manuela Liguori; Paola Allavena; Giovanna Chiorino; Ilaria Chiodi; Chiara Mondello
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

7.  Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry.

Authors:  Qingke Duan; Hengqiang Zhao; Zhengle Zhang; Hehe Li; Heshui Wu; Qiang Shen; Chunyou Wang; Tao Yin
Journal:  Sci Rep       Date:  2017-10-10       Impact factor: 4.379

Review 8.  When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance.

Authors:  Ching-Ying Kuo; David K Ann
Journal:  Cancer Commun (Lond)       Date:  2018-07-11

Review 9.  Emerging role of lipid metabolism alterations in Cancer stem cells.

Authors:  Mei Yi; Junjun Li; Shengnan Chen; Jing Cai; Yuanyuan Ban; Qian Peng; Ying Zhou; Zhaoyang Zeng; Shuping Peng; Xiaoling Li; Wei Xiong; Guiyuan Li; Bo Xiang
Journal:  J Exp Clin Cancer Res       Date:  2018-06-15

Review 10.  Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.

Authors:  Célia Cintas; Thibaut Douché; Nicole Therville; Silvia Arcucci; Fernanda Ramos-Delgado; Céline Basset; Benoît Thibault; Julie Guillermet-Guibert
Journal:  Cancers (Basel)       Date:  2018-06-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.